← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phylonix Pharmaceuticals, Inc.
Cambridge, MA
$17,731,953
Total funding
50
Grants
Funding over time
peak $2.2M · FY2005–12$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$17,731,953 · 50
By mechanism
R44$10,869,773 · 11
R43$6,862,180 · 39
Investigators at Phylonix Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Whole Animal Microplate Assay for Angiogenesis$577,843
R44 · FY2002 · CA
Novel Use of Zebrafish for Apoptosis Assay$514,925
R44 · FY2003 · CA
Novel Use of Zebrafish for Apoptosis Assay$478,538
R44 · FY2004 · CA
A New Model for Eye Disease$438,978
R44 · FY2006 · EY
Whole Animal Assay for Angiogenesis Inhibition$431,078
R44 · FY2002 · CA
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and$425,838
R44 · FY2009 · ES
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and$421,420
R44 · FY2008 · ES
Device for Automating Zebrafish Processing$413,650
R44 · FY2012 · GM
Device for Automating Zebrafish Processing$412,645
R44 · FY2011 · GM
In Vivo Ocular Angiogenesis Assay$408,176
R44 · FY2009 · EY
Zebrafish Screen for Ototoxic and Otoprotective Agents$406,935
R44 · FY2007 · DC
NOVEL METHOD FOR ORGAN TOXICITY$402,438
R44 · FY2000 · CA
A New Model for Eye Disease$394,867
R44 · FY2005 · EY
NOVEL METHOD FOR ORGAN TOXICITY$386,798
R44 · FY2001 · CA
Assay for Determining Drug Toxicity$383,497
R44 · FY2002 · CA
Assay for Determining Drug Toxicity$363,647
R44 · FY2003 · CA
In Vivo Screen for Neuroprotective Agents$357,590
R44 · FY2007 · NS
Whole Animal Assay for Angiogenesis Inhibition$344,139
R44 · FY2003 · CA
In Vivo Screen for Neuroprotective Agents$343,879
R44 · FY2008 · NS
In Vivo Ocular Angiogenesis Assay$334,807
R44 · FY2008 · EY